Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
No risk, no reward: Adding three new stores is more than just boss moves for Isaac Lee Collins; it’s betting his livelihood on going big
Kansas City’s frozen yogurt game is getting a major upgrade as Fifth & Emery Frozen Yogurt and Chocolate prepares to open three new locations in Zona Rosa, Olathe, and Lenexa this year. “I didn’t work this hard just to stop here,” said founder Isaac Lee Collins, who previously operated the venture as a handful of…
Heart-shaped goalllll: How city’s favorite parade of art, culture creates 150 openings for KC in 2026
Parade of Hearts scores new sculpture design as campaign looks down the pitch to World Cup potential A newly revealed sculpture design for the 2026 Parade of Hearts campaign is more than just the fiberglass from which it takes shape, Carmen Zuniga told a crowd gathered for a sneak peek at the prototype for the…
URL to IRL insights: KC analytics startup downloads $1.2M pre-seed round powered by coalition of VCs
The region’s investment community is rallying around an Overland Park tech startup that unlocks insights from videos online and beyond — and its trio of Kansas City founders is grateful to see local talent earning capital that more easily flows to coastal innovators. A $1.2 million pre-seed for dScribe AI is expected to fuel growth…
How KD Academy is redefining childcare as a pillar of KC’s economic growth
Editor’s note: The following story was written and first published by the Economic Development Corporation of Kansas City, Missouri (EDCKC). Click here to read the original story. In the heart of Kansas City, a state-of-the-art facility — embodying innovation in early childhood education and economic development — works day-in and day-out to meet the demands…